119 related articles for article (PubMed ID: 11053285)
1. Prevention of acute allergic conjunctivitis and late-phase inflammation with immunostimulatory DNA sequences.
Miyazaki D; Liu G; Clark L; Ono SJ
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3850-5. PubMed ID: 11053285
[TBL] [Abstract][Full Text] [Related]
2. Soluble P-selectin glycoprotein ligand 1 inhibits ocular inflammation in a murine model of allergy.
Strauss EC; Larson KA; Brenneise I; Foster CS; Larsen GR; Lee NA; Lee JJ
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1336-42. PubMed ID: 10359314
[TBL] [Abstract][Full Text] [Related]
3. Suppression of allergic response by CpG motif oligodeoxynucleotide-house-dust mite conjugate in animal model of allergic rhinitis.
Mo JH; Park SW; Rhee CS; Takabayashi K; Lee SS; Quan SH; Kim IS; Min IY; Raz E; Lee CH
Am J Rhinol; 2006; 20(2):212-8. PubMed ID: 16686392
[TBL] [Abstract][Full Text] [Related]
4. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis.
Won TB; Quan SH; Kim DY; Rhee CS; Lee CH
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):314-22. PubMed ID: 19441603
[TBL] [Abstract][Full Text] [Related]
5. Systemic or mucosal administration of immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitis.
Magone MT; Chan CC; Beck L; Whitcup SM; Raz E
Eur J Immunol; 2000 Jul; 30(7):1841-50. PubMed ID: 10940873
[TBL] [Abstract][Full Text] [Related]
6. Role of interferon-gamma in a mouse model of allergic conjunctivitis.
Stern ME; Siemasko K; Gao J; Duong A; Beauregard C; Calder V; Niederkorn JY
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3239-46. PubMed ID: 16123425
[TBL] [Abstract][Full Text] [Related]
7. Immunostimulatory DNA inhibits IL-4-dependent IgE synthesis by human B cells.
Horner AA; Widhopf GF; Burger JA; Takabayashi K; Cinman N; Ronaghy A; Spiegelberg HL; Raz E
J Allergy Clin Immunol; 2001 Sep; 108(3):417-23. PubMed ID: 11544462
[TBL] [Abstract][Full Text] [Related]
8. Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities.
Chisholm D; Libet L; Hayashi T; Horner AA
J Allergy Clin Immunol; 2004 Mar; 113(3):448-54. PubMed ID: 15007346
[TBL] [Abstract][Full Text] [Related]
9. Allergen-independent immunostimulatory sequence oligodeoxynucleotide therapy attenuates experimental allergic rhinitis.
Rhee CS; Libet L; Chisholm D; Takabayashi K; Baird S; Bigby TD; Lee CH; Horner AA; Raz E
Immunology; 2004 Sep; 113(1):106-13. PubMed ID: 15312141
[TBL] [Abstract][Full Text] [Related]
10. [Modulation of allergic airway inflammation by immunostimulatory DNA sequences in conjunction with an allergen in a murine model of asthma].
Jin M; Cai Y; Yuan Z; Zheng L; Ren T
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Sep; 25(9):542-5. PubMed ID: 12423563
[TBL] [Abstract][Full Text] [Related]
11. Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis.
Fukuda K; Ohbayashi M; Morohoshi K; Zhang L; Liu FT; Ono SJ
J Allergy Clin Immunol; 2009 Oct; 124(4):827-33.e2. PubMed ID: 19660804
[TBL] [Abstract][Full Text] [Related]
12. Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB/c mice.
Shoji J; Sakimoto T; Muromoto K; Inada N; Sawa M; Ra C
Jpn J Ophthalmol; 2005; 49(3):205-10. PubMed ID: 15944824
[TBL] [Abstract][Full Text] [Related]
13. Modulation of murine allergic rhinosinusitis by CpG oligodeoxynucleotides.
Hussain I; Jain VV; Kitagaki K; Businga TR; O'Shaughnessy P; Kline JN
Laryngoscope; 2002 Oct; 112(10):1819-26. PubMed ID: 12368622
[TBL] [Abstract][Full Text] [Related]
14. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2.
Tominaga T; Miyazaki D; Sasaki S; Mihara S; Komatsu N; Yakura K; Inoue Y
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5181-8. PubMed ID: 19553621
[TBL] [Abstract][Full Text] [Related]
15. Inducing ocular allergy with beta-lactoglobulin: a new experimental model.
Sari A; Dinc E; Yilmaz BC; Adiguzel U; Oztuna S; Tasdelen B
Ophthalmic Res; 2010; 44(2):119-24. PubMed ID: 20523103
[TBL] [Abstract][Full Text] [Related]
16. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
[TBL] [Abstract][Full Text] [Related]
17. Progress in the development of new methods of immunotherapy: potential application of immunostimulatory DNA-conjugated to allergens for treatment of allergic respiratory conditions.
Creticos PS; Lichtenstein LM
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):304-12; discussion 312-3. PubMed ID: 15119051
[TBL] [Abstract][Full Text] [Related]
18. Experimental model of allergic conjunctivitis to ragweed in guinea pig.
Merayo-Lloves J; Calonge M; Foster CS
Curr Eye Res; 1995 Jun; 14(6):487-94. PubMed ID: 7671631
[TBL] [Abstract][Full Text] [Related]
19. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
[TBL] [Abstract][Full Text] [Related]
20. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.
Tulic MK; Fiset PO; Christodoulopoulos P; Vaillancourt P; Desrosiers M; Lavigne F; Eiden J; Hamid Q
J Allergy Clin Immunol; 2004 Feb; 113(2):235-41. PubMed ID: 14767435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
